Pharmed (შპს ფარმედ) — Georgia Financials

Georgia Financials

panel 2026-09-21Ask

Pharmed (შპს ფარმედ) — Georgia Financials

as filed · GEL, thousands

Line item	2018	2019	2020	2021	2022	2023	2024	CAGR
	10,442	25,264	34,615	41,986	60,617	57,984	79,521	+40.3%
Total COGS	5,675	14,921	17,227	20,300	29,165	26,734	36,459	+36.3%
Gross Profit	4,767	10,342	17,388	21,686	31,452	31,250	43,061	+44.3%
Gross Margin	45.7%	40.9%	50.2%	51.6%	51.9%	53.9%	54.2%
	2,094	9,078	10,757	11,852	12,965	15,986	18,312	+43.5%
EBITDA	2,673	1,264	6,631	9,834	18,487	15,264	24,750	+44.9%
EBITDA Margin	25.6%	5.0%	19.2%	23.4%	30.5%	26.3%	31.1%
Total D&A	1	0	0	11	63	69	107	nmf
Impairment (non-financial)	0	0	0	0	0	45	204	+358.4%
EBIT / Operating Income	2,673	1,264	6,631	9,823	18,424	15,151	24,439	+44.6%
Total Interest Income	0	44	168	237	502	0	0	nmf
Total Interest Expense	0	4	27	0	0	0	0	+519.1%
	19	204	1,015	1,207	4,637	2,012	745	nmf
Profit Before Tax	2,653	1,508	7,787	8,852	14,288	17,162	25,184	+45.5%
Total Income Tax	0	0	0	0	0	0	0
Net Profit / (Loss)	2,653	1,463	7,787	10,786	14,288	17,162	25,184	+45.5%
Net Margin	25.4%	5.8%	22.5%	25.7%	23.6%	29.6%	31.7%